NEU neuren pharmaceuticals limited

Ann: Q2 2024 update, page-56

  1. 294 Posts.
    lightbulb Created with Sketch. 87

    To add to this, I believe Acadia quoted 66 patients iadded ‘as a fairly steady’ month on month progression. A straight up Q2 less Q1 calculation does not account for things like dropouts between cohorts as Ash mentioned but also pauses. We know anecdotally from the forums that pauses seem more likely in the early days as carers figure out G1 issues etc.

    But totally agree new patient persistence rate would be an interesting metric for them to report to see if there is any difference.
    Last edited by bigb888: 08/08/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.